Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | -2.01% | |
| Gapped Down | Weakness | -2.01% | |
| 50 DMA Resistance | Bearish | -6.87% | |
| Stochastic Reached Overbought | Strength | -6.87% | |
| Weak + Overbought | Other | -6.87% | |
| Overbought Stochastic | Strength | -6.87% | |
| Fell Below 50 DMA | Bearish | -4.31% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -4.31% | |
| Inside Day | Range Contraction | -4.31% | |
| Upper Bollinger Band Touch | Strength | -4.31% |
| Alert | Time |
|---|---|
| Up 1% | about 13 hours ago |
| 60 Minute Opening Range Breakout | about 15 hours ago |
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| Fell Below Previous Day's Low | about 17 hours ago |
| Down 2 % | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.04 |
| 52 Week Low | 4.22 |
| Average Volume | 43,313 |
| 200-Day Moving Average | 6.47 |
| 50-Day Moving Average | 5.24 |
| 20-Day Moving Average | 4.73 |
| 10-Day Moving Average | 4.78 |
| Average True Range | 0.36 |
| RSI (14) | 48.98 |
| ADX | 27.85 |
| +DI | 21.68 |
| -DI | 15.61 |
| Chandelier Exit (Long, 3 ATRs) | 4.47 |
| Chandelier Exit (Short, 3 ATRs) | 5.31 |
| Upper Bollinger Bands | 5.37 |
| Lower Bollinger Band | 4.10 |
| Percent B (%b) | 0.61 |
| BandWidth | 26.76 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.16 |
| MACD Histogram | 0.1002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.20 | ||||
| Resistance 3 (R3) | 5.22 | 5.13 | 5.14 | ||
| Resistance 2 (R2) | 5.13 | 5.05 | 5.12 | 5.12 | |
| Resistance 1 (R1) | 5.01 | 5.00 | 4.97 | 4.99 | 5.11 |
| Pivot Point | 4.92 | 4.92 | 4.90 | 4.91 | 4.92 |
| Support 1 (S1) | 4.80 | 4.84 | 4.76 | 4.78 | 4.65 |
| Support 2 (S2) | 4.71 | 4.79 | 4.70 | 4.64 | |
| Support 3 (S3) | 4.59 | 4.71 | 4.62 | ||
| Support 4 (S4) | 4.57 |
